Clinical Trials Browser

Fallopian Tube Neoplasms × carotuximab × Clear all

NCT01381861 2019-03-05

Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Phase 2 Completed

23 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms